Merck and Ridgeback’s Molnupiravir Receives U.S. FDA...
Fax: 215-616-5677 E-mail: dpoc.usa@merck.com About Molnupiravir Molnupiravir (MK-4482 and EIDD-2801) is an investigational, orally administered nucleoside analogue that inhibits replication of SARS-CoV-2, the causative agent of COVID-1...